New York University Medical Center (Site 200)

New York, New York 10016

0 studies enrolling now · 2 studies all time

What they study most

Low-grade Glioma, NF1, Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS)

Studies at this site

• Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas — Completed
• A Phase II Trial of Poly-ICLC for Low-Grade Gliomas — Stopped early